Nature's Sunshine’s (NASDAQ:NATR) Q3: Strong Sales

Wellness products company Nature’s Sunshine (NASDAQ:NATR) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 12% year on year to $128.3 million. The company’s full-year revenue guidance of $478 million at the midpoint came in 2.3% above analysts’ estimates. Its non-GAAP profit of $0.36 per share was significantly above analysts’ consensus estimates. Is now the time to buy Nature's Sunshine? Find out in our full research report. Nature's Sunshine (NATR) Q3 CY2025 Highlights: Revenue: $12 ...